Skip to content

Author

Shahrzad Ashena

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Association of Three HIF‐1α Genotypes With Susceptibility and Severity of Chronic Kidney Disease

ABSTRACT Hypoxic signaling is a critical factor in the pathogenesis of Chronic Kidney Disease (CKD). Hypoxia‐Inducible Factor 1 (HIF‐1) is a transcription factor that is highly expressed in the kidney and is associated with renal tubular hypoxic adaptation. Variation in the HIF‐1α subunit gene has been associated with...

Hanifa Aktar, Shahrzad Ashena, Mohammad Sanaei Ardekani et al. · 0 citations
Open access Oct 2026

Implementation of Rapid CYP2C19 Genotyping to Guide Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack.

Clopidogrel is first-line for secondary stroke prevention, but its effectiveness is affected by CYP2C19 genetic variation. An American Heart Association (AHA) scientific statement concluded that CYP2C19-guided P2Y12 inhibitor (P2Y12i) therapy is evidence-supported, though real-world application depends on implementatio...

D. M. Smith, Pamela Ramos Ramos, Shahrzad Ashena et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.